S&P 500   3,951.57 (+0.89%)
DOW   32,244.58 (+1.20%)
QQQ   305.97 (+0.20%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
S&P 500   3,951.57 (+0.89%)
DOW   32,244.58 (+1.20%)
QQQ   305.97 (+0.20%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
S&P 500   3,951.57 (+0.89%)
DOW   32,244.58 (+1.20%)
QQQ   305.97 (+0.20%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
S&P 500   3,951.57 (+0.89%)
DOW   32,244.58 (+1.20%)
QQQ   305.97 (+0.20%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
LON:OBD

Oxford BioDynamics - OBD Share Forecast, Price & News

GBX 15.25
-1.00 (-6.15%)
(As of 03/20/2023 04:05 PM ET)
Add
Compare
Today's Range
15.11
▼
15.70
50-Day Range
13.65
▼
20
52-Week Range
10.98
▼
29.50
Volume
139,891 shs
Average Volume
247,655 shs
Market Capitalization
£22.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

OBD stock logo

About Oxford BioDynamics (LON:OBD) Stock

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures for use in medical testing kits, disease prediction, diagnosis, and treatment. Its products include EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a validated prognostic test for predicting response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling and biomarker discovery. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.

Receive OBD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford BioDynamics and its competitors with MarketBeat's FREE daily newsletter.

OBD Stock News Headlines

March 12, 2023 | americanbankingnews.com
Oxford BioDynamics (LON:OBD) Trading Down 3.9%
February 10, 2023 | msn.com
This blood test can detect prostate cancer with 94 percent accuracy
March 20, 2023 | Investing Daily (Ad)
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate. pixel
February 8, 2023 | msn.com
Scientists create ‘impressive’ new blood test for prostate cancer that is 94% accurate
February 7, 2023 | msn.com
New blood test for prostate cancer is 94% accurate, researchers say
February 2, 2023 | finance.yahoo.com
The Non-Executive Director of Oxford BioDynamics Plc (LON:OBD), Stephen Diggle, Just Bought A Few More Shares
January 29, 2023 | finance.yahoo.com
Oxford BioDynamics Full Year 2022 Earnings: UK£0.067 loss per share (vs UK£0.072 loss in FY 2021)
December 19, 2022 | finance.yahoo.com
Oxford BioDynamics in San Francisco for the 41st Annual J.P. Morgan Healthcare Conference
March 20, 2023 | Behind the Markets (Ad)
Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
December 16, 2022 | finance.yahoo.com
Massachusetts General Hospital Reports Results of Interim Analysis from REFINE-ALS Biomarker Trial by Mitsubishi Tanabe Pharma USA, Utilizing Oxford Biodynamics’ EpiSwitch® Platform for Prognostic Stratification of Fast Progression ALS
October 8, 2022 | fool.co.uk
Oxford BioDynamics
October 8, 2022 | finance.yahoo.com
Oxford BioDynamics (LON:OBD) Will Have To Spend Its Cash Wisely
October 7, 2022 | marketwatch.com
Oxford BioDynamics to Raise Up to GBP12 Mln to Boost Cancer Test Commercialization
June 28, 2022 | lse.co.uk
Oxford BioDynamics shares drop as it might need funding by early 2023
June 21, 2022 | barrons.com
Oxford BioDynamics's Checkpoint Inhibitor Response Test (EpiSwitch(R) CiRT) Now Available in the UK
March 11, 2022 | finance.yahoo.com
Oxford BioDynamics Plc (OBD.L)
November 22, 2021 | finance.yahoo.com
Is Oxford BioDynamics (LON:OBD) In A Good Position To Deliver On Growth Plans?
October 25, 2021 | marketwatch.com
Armistice Capital Invests GBP3.6 Mln in Oxford BioDynamics
August 31, 2021 | lse.co.uk
Geronimo the alpaca euthanised in Britain despite public outcry
August 31, 2021 | lse.co.uk
TRADING UPDATES: Jet2 in bumper Airbus order; Strix China factory live
August 31, 2021 | lse.co.uk
Ryanair predicts strong recovery, ups passenger target
August 31, 2021 | lse.co.uk
Oxford BioDynamics awarded $0.91m US PACT grant
August 31, 2021 | finance.yahoo.com
Oxford BioDynamics Awarded US FNIH Grant to Apply EpiSwitch® Immune Health Test for Improved Prediction of Patient Response to Immune Checkpoint Inhibitor (ICI) Cancer Therapies
July 29, 2021 | marketwatch.com
Genetic Testing Market is projected to manifest the fastest CAGR of 11.53% through 2027
March 31, 2021 | finance.yahoo.com
Oxford BioDynamics signs supply and resale agreement with Agilent Technologies, and launches EpiSwitch® Explorer Array Kit for R&D use
March 23, 2021 | fool.co.uk
The Oxford BioDynamics share price is up 30% today. Here’s what I’d do now
March 23, 2021 | lse.co.uk
Oxford Biodyn Share News (OBD)
See More Headlines
Receive OBD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford BioDynamics and its competitors with MarketBeat's FREE daily newsletter.

OBD Company Calendar

Last Earnings
6/16/2020
Today
3/20/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
LON:OBD
CUSIP
N/A
CIK
N/A
Web
www.oxfordbiodynamics.com
Phone
+44-1865-518910
Fax
N/A
Employees
39
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
GBX (0.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-6,710,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-144.60%
Return on Assets
-40.23%

Debt

Debt-to-Equity Ratio
237.09
Current Ratio
0.95
Quick Ratio
2.80

Sales & Book Value

Annual Sales
£176,000.00
Price / Sales
127.12
Cash Flow
GBX 3.83 per share
Price / Cash Flow
3.98
Book Value
GBX 3 per share
Price / Book
5.08

Miscellaneous

Outstanding Shares
146,710,000
Free Float
N/A
Market Cap
£22.37 million
Optionable
Not Optionable
Beta
1.18

Key Executives

  • Dr. Jon Anthony Joseph Burrows B.Sc. (Age 59)
    M.Sc., Ph.D., CEO & Director
    Comp: $463k
  • Mr. Paul Leslie Stockdale F.C.A. (Age 47)
    M.A., CFO & Director
    Comp: $202k
  • Dr. Alexandre Akoulitchev Ma (Oxon) (Age 60)
    Ph.D., Chief Scientific Officer & Director
    Comp: $236k
  • Mr. Thomas G. Guiel B.A.
    Chief Operating Officer
  • Dr. Jayne Green B.Sc.
    Ph.D., Director of Operations
  • Dr. Ewan Hunter B.Sc.
    BSC, Ph.D., Ph.D., (KCL), C.D.O
  • T. Demain
    Company Sec.
  • Dr. Steven Tucker M.D.
    FACP, Group Clinical Director
  • Prof. Siamon Gordon
    Clinical Director of Inflammation & Infection
  • Dr. Sandy Primrose Ph.D.
    Technical Consultant

Key Competitors

View All Competitors

Insiders

View All Insider Transactions













OBD Stock - Frequently Asked Questions

How have OBD shares performed in 2023?

Oxford BioDynamics' stock was trading at GBX 17.15 on January 1st, 2023. Since then, OBD stock has decreased by 11.1% and is now trading at GBX 15.25.
View the best growth stocks for 2023 here.

How were Oxford BioDynamics' earnings last quarter?

Oxford BioDynamics Plc (LON:OBD) posted its quarterly earnings results on Tuesday, June, 16th. The biotechnology company reported ($2.20) earnings per share for the quarter.

What other stocks do shareholders of Oxford BioDynamics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oxford BioDynamics investors own include Oxford Biomedica (OXB), Frontline (FRO), Fate Therapeutics (FATE), Cargojet (CJT), China Unicom (Hong Kong) (CHU), Casey's General Stores (CASY), Buckle (BKE), Biffa (BIFF), AXT (AXTI) and Grupo Aval Acciones y Valores (AVAL).

What is Oxford BioDynamics' stock symbol?

Oxford BioDynamics trades on the London Stock Exchange (LON) under the ticker symbol "OBD."

How do I buy shares of Oxford BioDynamics?

Shares of OBD stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Oxford BioDynamics' stock price today?

One share of OBD stock can currently be purchased for approximately GBX 15.25.

How much money does Oxford BioDynamics make?

Oxford BioDynamics (LON:OBD) has a market capitalization of £22.37 million and generates £176,000.00 in revenue each year. The biotechnology company earns £-6,710,000.00 in net income (profit) each year or GBX (0.06) on an earnings per share basis.

How can I contact Oxford BioDynamics?

Oxford BioDynamics' mailing address is 26 Beaumont Street, OXFORD, OX1 2NP, United Kingdom. The official website for the company is www.oxfordbiodynamics.com. The biotechnology company can be reached via phone at +44-1865-518910.

This page (LON:OBD) was last updated on 3/20/2023 by MarketBeat.com Staff